Version 1 : Received: 23 April 2021 / Approved: 26 April 2021 / Online: 26 April 2021 (20:14:21 CEST) Version 2 : Received: 27 April 2021 / Approved: 28 April 2021 / Online: 28 April 2021 (17:18:50 CEST) Version 3 : Received: 17 May 2021 / Approved: 18 May 2021 / Online: 18 May 2021 (14:05:33 CEST)
How to cite: Perez, J. The INDIA Mutations and B.1.617 Variant:Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?. Preprints2021, 2021040689. https://doi.org/10.20944/preprints202104.0689.v1 Perez, J. The INDIA Mutations and B.1.617 Variant: Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?. Preprints 2021, 2021040689. https://doi.org/10.20944/preprints202104.0689.v1
Perez, J. The INDIA Mutations and B.1.617 Variant:Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?. Preprints2021, 2021040689. https://doi.org/10.20944/preprints202104.0689.v1
APA Style
Perez, J. (2021). The INDIA Mutations and B.1.617 Variant:<i> </i>Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?. Preprints. https://doi.org/10.20944/preprints202104.0689.v1
Chicago/Turabian Style
Perez, J. 2021 "The INDIA Mutations and B.1.617 Variant:<i> </i>Is There a Global "Strategy" for Mutations and Evolution of Variants of The SARS-CoV2 Genome?" Preprints. https://doi.org/10.20944/preprints202104.0689.v1
Abstract
In this paper, we run for all INDIA mutations and variants a biomathematical numerical method for analysing mRNA nucleotides sequences based on UA/CG Fibonacci numbers proportions (Perez, 2021). In this study, we limit ourselves to the analysis of whole genomes, all coming from the mutations and variants of SARS-CoV2 sequenced in India in 2020 and 2021. We then demonstrate - both on actual genomes of patients and on variants combining the most frequent mutations to the SARS-CoV2 Wuhan genomes and then to the B.1.617 variant - that the numerical Fibonacci AU / CG metastructures increase considerably in all cases analyzed in ratios of up to 8 times. We can affirm that this property contributes to a greater stability and lifespan of messenger RNAs, therefore, possibly also to a greater INFECTUOSITY of these variant genomes.
Keywords
SARS-CoV2; Biomathematics; vaccine; variants; mRNA; Fibonacci; Indian variants; B.1.617
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
